Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules

Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules

by Christopher Janson, Matthew During

274 pages· 2007· ISBN 9780387329567
About
This volume is unique to the existing literature in the Peptide Nucleic Acid field, in that it focuses on comparing and contrasting PNA with other available oligonucleotide homologues and considers areas in which these biomolecules could be profitably applied to clinical and diagnostic applications. Part I of the book addresses comparative strengths and weaknesses of various nucleoside homologues. Part II of the book addresses specific translational or clinical applications for PNA and related antisense biomolecules. The editors have succeeded in presenting a balanced yet broad view of the methods available for gene targeting and modification.

Discuss Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules with other readers

Join or start a book club for Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules?

Sign up free on Readfeed, then browse public clubs or start your own club with Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.